Items where authors include "Hirschberg, A.L."

Article

Arlt, W. orcid.org/0000-0001-5106-9719, Brac de la Perrière, A. orcid.org/0000-0001-6453-8326, Hirschberg, A.L. orcid.org/0000-0001-6481-6277 et al. (10 more authors) (2025) Long-term outcomes in patients with congenital adrenal hyperplasia treated with hydrocortisone modified-release hard capsules. European Journal of Endocrinology, 193 (1). pp. 76-84. ISSN 0804-4643

Ross, R.J.M. orcid.org/0000-0001-9222-9678, Arlt, W. orcid.org/0000-0001-5106-9719, de la Perriere, A.B. et al. (13 more authors) (2025) Switching patients with congenital adrenal hyperplasia to modified‐release hydrocortisone capsules: relative bioavailability and disease control. Clinical Endocrinology. ISSN 0300-0664

Paschou, S.A., Athanasiadou, K.I., Hafford-Letchfield, T. et al. (16 more authors) (2024) Sexual health and wellbeing and the menopause: An EMAS clinical guide. Maturitas, 189. 108055. ISSN 0378-5122

Merke, D.P., Mallappa, A., Arlt, W. et al. (14 more authors) (2020) OR25-02 A phase 3 study of a modified-release hydrocortisone in the treatment of congenital adrenal hyperplasia. Journal of the Endocrine Society, 4 (Supplement_1).

Proceedings Paper

Lawrence, N.R. orcid.org/0000-0002-7560-0268, Krone, N.P., Dawson, J.F. et al. (15 more authors) (2024) 6437 Analysis of 17-OH-progesterone (17OHP) and androstenedione (A4) profiles to rationalise biochemical monitoring of CAH patients. In: Journal of the Endocrine Society. ENDO 2024 Abstracts Annual Meeting of the Endocrine Society, 01-04 Jun 2024, Boston, USA. The Endocrine Society .